| Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease JB Canavan, C Scottà, A Vossenkämper, R Goldberg, MJ Elder, I Shoval, ... Gut 65 (4), 584-594, 2016 | 201 | 2016 |
| The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD R Goldberg, N Prescott, GM Lord, TT MacDonald, N Powell Nature reviews Gastroenterology & hepatology 12 (5), 271-283, 2015 | 107 | 2015 |
| Interleukin 6 increases production of cytokines by colonic innate lymphoid cells in mice and patients with chronic intestinal inflammation N Powell, JW Lo, P Biancheri, A Vossenkämper, E Pantazi, AW Walker, ... Gastroenterology 149 (2), 456-467. e15, 2015 | 97 | 2015 |
| Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities SX Cho, I Rudloff, JC Lao, MA Pang, R Goldberg, CB Bui, CA McLean, ... Nature communications 11 (1), 5794, 2020 | 68 | 2020 |
| Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease K Soderquest, A Hertweck, C Giambartolomei, S Henderson, R Mohamed, ... PLoS genetics 13 (2), e1006587, 2017 | 48 | 2017 |
| Correction of defective T-regulatory cells from patients with Crohn’s disease by ex vivo ligation of retinoic acid receptor-α R Goldberg, C Scotta, D Cooper, E Nissim-Eliraz, E Nir, S Tasker, ... Gastroenterology 156 (6), 1775-1787, 2019 | 45 | 2019 |
| Toxicity and response to thiopurines in patients with inflammatory bowel disease R Goldberg, PM Irving Expert review of gastroenterology & hepatology 9 (7), 891-900, 2015 | 43 | 2015 |
| Seasonal recurrence of food bolus obstruction in eosinophilic esophagitis HL Philpott, S Nandurkar, F Thien, S Bloom, E Lin, R Goldberg, ... Internal Medicine Journal 45 (9), 939-943, 2015 | 40 | 2015 |
| Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres MA Samaan, P Pavlidis, E Johnston, B Warner, J Digby-Bell, ... Frontline Gastroenterology 8 (3), 196-202, 2017 | 39 | 2017 |
| Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero E Flanagan, R Prentice, EK Wright, PR Gibson, AL Ross, J Begun, ... Alimentary Pharmacology & Therapeutics 55 (6), 700-704, 2022 | 25 | 2022 |
| ECCO topical review: refractory inflammatory bowel disease T Raine, B Verstockt, U Kopylov, K Karmiris, R Goldberg, R Atreya, ... Journal of Crohn's and Colitis 15 (10), 1605-1620, 2021 | 19 | 2021 |
| Thiopurine metabolite testing in inflammatory bowel disease R Goldberg, G Moore, G Cunningham, J Schulberg, P Marsh, S Brown, ... Journal of gastroenterology and hepatology 31 (3), 553-560, 2016 | 18 | 2016 |
| Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B. R Goldberg, E Smith, S Bell, A Thompson, PV Desmond Internal Medicine Journal 43 (7), 2013 | 16 | 2013 |
| Resolving intestinal fibrosis through regenerative medicine R Schwab, R Lim, R Goldberg Current Opinion in Pharmacology 49, 90-94, 2019 | 11 | 2019 |
| Recombinant activated factor VII for a warfarinised Jehovah’s Witness with an acute subdural haematoma R Goldberg, KJ Drummond Journal of Clinical Neuroscience 15 (10), 1164-1166, 2008 | 11 | 2008 |
| A crohn’s Disease-associated IL2RA enhancer variant determines the balance of t cell immunity by regulating responsiveness to IL-2 signalling R Goldberg, JN Clough, LB Roberts, J Sanchez, S Kordasti, N Petrov, ... Journal of Crohn's and Colitis 15 (12), 2054-2065, 2021 | 7 | 2021 |
| How accurate are hospital scales? R Goldberg, G Hebbard The Medical Journal of Australia 194 (12), 665, 2011 | 3 | 2011 |
| The interplay between the microbiota, diet and T regulatory cells in the preservation of the gut barrier in inflammatory bowel disease K Prame Kumar, JD Ooi, R Goldberg Frontiers in Microbiology 14, 1291724, 2023 | 2 | 2023 |
| P378 Pharmacokinetics of Vedolizumab and Ustekinumab in pregnant women with Inflammatory Bowel Disease and their infants exposed in-utero R Prentice, E Flanagan, EK Wright, PR Gibson, S Rosella, O Rosella, ... Journal of Crohn's and Colitis 17 (Supplement_1), i508-i510, 2023 | 2 | 2023 |
| 676 Phamracokinetics Of Vedolizumab And Ustekinumab In Pregnant Women With Inflammatory Bowel Disease And Their Infants Exposed In-Utero R Prentice, E Flanagan, EK Wright, PR Gibson, S Rosella, O Rosella, ... Gastroenterology 164 (6), S-133, 2023 | 1 | 2023 |
